GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

New Retina Radio by Eyetube
28/10/2024 22 min
GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

Listen "GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?"

Descargar episodio

Episode Synopsis

We finally have two FDA-approved treatments for geographic atrophy (GA)—and yet, many retina specialists have been reluctant to embrace them. Join moderator John Kitchens, MD, as he explores this question with Miguel Busquets, MD, and Esther Kim, MD. Further in the episode, they gameplan patient conversations centered around choosing a treatment, ask how heavily to weigh safety when selecting a complement inhibitor, and preview the GA pipeline.

More episodes of the podcast New Retina Radio by Eyetube

New Retina Radio Journal Club w/ VBS: Time-Driven Cost Analysis of PRP: Dollars, Minutes, and Patient Care 10/10/2025
The Nuts and Bolts of GA Therapy: The Opening Sessions 09/10/2025
Keeping Patients at the Center of GA Therapy: Preserving Vision vs Restoring Vision 02/10/2025
Keeping Patients at the Center of GA Therapy: Dosing Schedules, AREDS Vitamins, and Photobiomodulation 02/10/2025
Keeping Patients at the Center of GA Therapy: Patient Education and Setting Expectations 02/10/2025
Keeping Patients at the Center of GA Therapy: Social Impact and Early Intervention 02/10/2025
New Retina Radio Journal Club w/ VBS: Aflibercept 8 mg in nAMD: Outcomes After Switching From Faricimab 26/09/2025
ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDR 04/09/2025
ASRS '25: PORTAL 5-year Data in Wet AMD, and Home OCT vs Human Graders 21/08/2025
New Retina Radio Journal Club w/ VBS: Obstructive Sleep Apnea and Diabetic Retinopathy 13/08/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA